Who we are

BioCurate is a bold, collaborative venture, dedicated to translating Australian medical research and delivering health and economic benefits to the world. Created jointly by two of Australia’s leading biomedical universities, the University of Melbourne and Monash University, we are operationally independent with an absolute commitment to rigorous science and partnering closely with researchers to help conquer the challenges which stand between great ideas and global impact. We can help you change the future.

We bridge the gap

Our collaborative team of global biomedical experts bridge the gap between:

Ideas + Impact
Research + Translation
Discovery + Commercialisation
Academia + Industry

What we are doing

This is the excerpt text that briefly describes what the page is about.
Text on the button
BioCurate is operationally independent of the Universities and has an independent Board Chair, the Hon John Brumby, AO. Mr Brumby is an eminent Australian with demonstrated leadership and commitment to innovation. He is supported by a highly experienced Board of Directors with specialist backgrounds in biotechnology and/or drug development commercialisation, investment and corporate governance.
Text on the button
Text on the button

Staff profiles

Meet Glenn Begley

Chief Executive Officer

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna. Lorem ipsum dolor sit amet, conse ctetur add do eiusmod tempor…

Read more about Glenn
See all profiles

Meet Glenn Begley

Chief Executive Officer

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna. Lorem ipsum dolor sit amet, conse ctetur add do eiusmod tempor…

Read more about Glenn
See all profiles

Our team

150
Has over 150 years of combined biotech/pharma industry experience

35
Has been directly involved in over 35 Investigational New Drug applications (INDs)

70
Are responsible for 70 therapeutics currently in the clinic

$2.1B
Were directly involved in 15 deals worth a cumulative total of over $2.1 billion

Twitter feed

BioCurate Follow 1,572 1,837

A joint venture between @monashuni & @unimelb to catalyse the translation of #biomedical & #biopharma research toward commercialisation. #Discoveries2Drugs

BioCurate
BioCurate @BioCurate ·
8 Nov 1722052879010107824

Thank you #AusBio2023!

BioCurate had a wonderful time in Brisbane last week, reconnecting with peers, engaging in important discussions about the current state and future ambitions of Australia's biotech industry, and helping the development of the next generation of innovators.

Twitter feed video.
Reply on Twitter 1722052879010107824 Retweet on Twitter 1722052879010107824 0 Like on Twitter 1722052879010107824 1 Twitter 1722052879010107824
BioCurate @BioCurate ·
1 Nov 1719842917295272140

Thank you Hit ID Symposium 2023!It was exciting to see fantastic talks covering a range of topics in drug development, starting at hit ID all the way through to the clinic and the market, being delivered to a deeply engaged and invested audience.

Image for the Tweet beginning: Thank you Hit ID Symposium Twitter feed image.
Reply on Twitter 1719842917295272140 Retweet on Twitter 1719842917295272140 0 Like on Twitter 1719842917295272140 1 Twitter 1719842917295272140
Retweet on Twitter BioCurate Retweeted
Innovation2Translation! @Innovation2T ·
30 Oct 1718905234213494949

Abstract deadline extended until Monday 6th Nov to participate in the #I2T2023 pitch session.

http://form.jotform.com/232401390404847

Don't miss out!
⭐ Feedback from commercialization experts.
💲Total prize money of $30k for best speakers.
🗓 Tue, 5th Dec 23
📍 Woodward Conference Centre

Image for the Tweet beginning: Abstract deadline extended until Monday Twitter feed image.
Reply on Twitter 1718905234213494949 Retweet on Twitter 1718905234213494949 4 Like on Twitter 1718905234213494949 5 Twitter 1718905234213494949
Retweet on Twitter BioCurate Retweeted
ARC Centre for Fragment-Based Design @ARC_CFBD ·
27 Oct 1717741514770755804

Resuming after a short lunch break with a panel session on funding sources. Susie Nilsson from @CSIRO chairing the session wit MedChem Australia, Oncology One, @TIA_Aust ,@BioCurate and @brandoncapital’s Cureator.

Image for the Tweet beginning: Resuming after a short lunch Twitter feed image.
Reply on Twitter 1717741514770755804 Retweet on Twitter 1717741514770755804 2 Like on Twitter 1717741514770755804 8 Twitter 1717741514770755804

Life changing therapies in the Australian regenerative medicine sector

“Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehend. Excepteur sint occaecat cupidatat non proident, sunt inlit anim id est laborum.”

Life changing therapies in the Australian regenerative medicine sector

“Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehend. Excepteur sint occaecat cupidatat non proident, sunt inlit anim id est laborum.”